Diagnostic, Prognostic and Predictive Biological Markers in Bladder Cancer - Illumination of a Vision 2.0

• Eará dahkkit: Ecke, Thorsten (Doaimmaheaddji), Otto, Thomas (Doaimmaheaddji)
• Materiálatiipa: Elektrovnnalaš Girjji oassi
• Giella: eaŋgalasgiella
• Almmustuhtton: Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2021
• Fáttát: Medicine; Metallothionein; urothelium; urothelial cancer; cadmium exposure; zinc transporter; bladder; TAGLN; F-actin; PTEN; p53; tumorigenesis; proliferation; invasion; TERT promoter mutations; FGFR3; non muscle invasive bladder cancer; BCG therapy; bladder cancer; JAK-STAT pathway; combination therapy; oncolytic adenovirus; virotherapy; STAT3/5 inhibitor; JAK inhibitor; XVir-N-31; bladder cancer detection; urinary biomarkers; DNA methylation; ECRG4; ITIH5; n/a; biomarker; cancer; grade; metabolomics; MS; NMR; biomarkers; tumor markers; prognosis; heparanase; syndecan-1; heparan sulfate proteoglycans (HSPGs); urothelial carcinoma; miRNA; quantitative PCR; tumor marker; voided urine cytology; KDM7A; histone demethylase; TC-E 5002; androgen receptor; drug resistance; non-invasive detection; telomerase; somatic mutations; TERT promoter region; muscle-invasive bladder cancer; chemotherapy; immunotherapy; personalized medicine; predictive biomarker; survivin; BIRC5; macrophage; KRT20; ERBB2; MIBC; prediction; RT-qPCR; adjuvant chemotherapy; survival
• Liŋkkat: DOAB: download the publication; DOAB: description of the publication

After our successful first Special Issue about bladder cancer, we proceeded with the second issue. Again, many international scientists submitted their newest research results in that extremely interesting field and followed our call for submissions. It is not only the collection and combination of...